On September 17, 2021, the U.S. Departments of Health and Human Services and Treasury finalized the 2022 Notice of Benefit and Payment Parameters (NBPP) rule and announced a significant expansion of their oversight of health plans’ provider networks. This expert perspective reviews provisions of the rule of particular import to the state-based marketplaces (SBMs) and state insurance regulators.
Medicaid Buy-In: State Options, Design Considerations and Section 1332 Waiver Implications
Patricia Boozang, Chiquita Brooks-LaSure and Ashley Traube, Manatt Health
States continue to identify and pursue strategies to further reduce the number of uninsured, to make coverage more affordable for consumers and to improve access to care. Several proposals have been introduced at both the federal and state levels that would permit people above Medicaid eligibility levels to “buy in” to Medicaid or would leverage the Medicaid program to strengthen coverage across the individual market and Medicaid. This issue brief presents two possible models for a Medicaid buy-in program for states, and details the design considerations and authorities needed to implement each model.
The State Health Policy Highlight, Medicaid Buy-In: What Is It? And How Can It Be Useful to States? provides an overview of the concept of Medicaid buy-in and outlines the issues states can solve for by implementing a Medicaid buy-in program.
State Health and Value Strategies hosted a companion webinar, Medicaid Buy-in: State Options and Design Considerations based on the issue brief that provided an overview on Medicaid buy-in and explored the two models profiled in the issue brief.